DRDO’s anti-Covid drug 2DG. (Representational picture)
Dr Reddy’s on Wednesday launched important information regarding drug 2-deoxy-D-glucose (2DG), developed by INMAS, a DRDO lab in collaboration with Dr. Reddy’s Laboratories.
Listing out important information regarding the brand new anti-Covid drug, Dr Reddy’s mentioned, “emergency use approval has been granted in India for anti-Covid-19 therapeutic application of the drug 2-deoxy-D-glucose (2DG) developed by INMAS, a lab of the DRDO, in collaboration with Dr Reddy’s laboratories.”
“2DG is an oral anti-viral drug that can be administered only upon prescription to hospitalised moderate to severe Covid-19 patients as adjunct (add on) therapy along with existing standard of care,” Dr Reddy’s mentioned.
ALSO READ | DRDO developed 2-DG drug might be game-changer in struggle in opposition to Covid, says Minister
2DG’s market availability and worth
“2DG has not been launched into the market. Price per sachet has not yet been announced,” Dr Reddy’s knowledgeable.
2DG’s industrial launch date
The industrial launch and provide of 2DG to main authorities and personal hospitals is predicted to start in mid-June. Price is being detemined with a view to creating it accessible and inexpensive to as many as attainable and wil be introduced quickly.
“Please beware of agents selling spurious or illegal products in the name of 2DG and also regarding the unverfied messages relating to 2DG circulating on social media and on WhatsApp,” Dr Reddy’s mentioned.
ALSO READ | DRDO imports zeolite to make oxygen for COVID-hit
